Literature DB >> 17579828

Impact of the peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta) Ala203Pro polymorphism on in vivo metabolism, PGC-1beta expression and fibre type composition in human skeletal muscle.

C Ling1, L Wegner, G Andersen, P Almgren, T Hansen, O Pedersen, L Groop, A Vaag, P Poulsen.   

Abstract

AIMS/HYPOTHESIS: Peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta, also known as PPARGC1B) expression is reduced in skeletal muscle from patients with type 2 diabetes mellitus and in elderly subjects. Ala203Pro, a common variant in the PGC-1beta gene is associated with obesity. The aim of this study was to investigate whether the PGC-1beta Ala203Pro polymorphism influences the age-related decline in skeletal muscle PGC-1beta expression, in vivo metabolism and markers for muscle fibre type composition.
MATERIALS AND METHODS: The PGC-1beta Ala203Pro polymorphism was genotyped in 110 young (age 28.0 +/- 1.9 years) and 86 elderly (age 62.4 +/- 2.0 years) twins and related to muscle PGC-1beta expression, in vivo metabolism and markers for fibre type composition.
RESULTS: Insulin-stimulated non-oxidative glucose metabolism (NOGM; p = 0.025) and glycolytic flux rate (GF; p = 0.026) were reduced in young Ala/Ala carriers compared with carriers of a 203Pro allele. In addition, a regression analysis, correcting for covariates, showed that the PGC-1beta 203Pro allele was positively related to insulin-stimulated NOGM and GF in the young twins. While muscle expression of PGC-1beta was reduced in elderly compared with young carriers of the Ala/Ala genotype (p < or = 0.001), there was no significant age-related decline in PGC-1beta expression in carriers of the 203Pro allele (p > or = 0.4). However, a regression analysis, correcting for covariates, showed that only age was significantly related to muscle PGC-1beta expression. Finally, PGC-1beta expression correlated positively with markers for oxidative fibres in human muscle. CONCLUSIONS/
INTERPRETATION: This study suggests that young carriers of a PGC-1beta 203Pro allele have enhanced insulin-stimulated glucose metabolism and may be protected against an age-related decline in PGC-1beta expression in muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579828     DOI: 10.1007/s00125-007-0729-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle.

Authors:  Zoltan Arany; Nathan Lebrasseur; Carl Morris; Eric Smith; Wenli Yang; Yanhong Ma; Sherry Chin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2007-01       Impact factor: 27.287

2.  Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight.

Authors:  Christine B Jensen; Heidi Storgaard; Flemming Dela; Jens Juul Holst; Sten Madsbad; Allan A Vaag
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

Review 4.  Regression analysis for correlated data.

Authors:  K Y Liang; S L Zeger
Journal:  Annu Rev Public Health       Date:  1993       Impact factor: 21.981

5.  Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.

Authors:  J Ek; G Andersen; S A Urhammer; P H Gaede; T Drivsholm; K Borch-Johnsen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2001-12       Impact factor: 10.122

Review 6.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

Authors:  Pere Puigserver; Bruce M Spiegelman
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

7.  PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity.

Authors:  Yasutomi Kamei; Hiroshi Ohizumi; Yasushi Fujitani; Tomoyuki Nemoto; Toshiya Tanaka; Nobuyuki Takahashi; Teruo Kawada; Masamitsu Miyoshi; Osamu Ezaki; Akira Kakizuka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

8.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

9.  Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins.

Authors:  Charlotte Ling; Pernille Poulsen; Emma Carlsson; Martin Ridderstråle; Peter Almgren; Jørgen Wojtaszewski; Henning Beck-Nielsen; Leif Groop; Allan Vaag
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

10.  Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.

Authors:  Christopher J Lelliott; Gema Medina-Gomez; Natasa Petrovic; Adrienn Kis; Helena M Feldmann; Mikael Bjursell; Nadeene Parker; Keira Curtis; Mark Campbell; Ping Hu; Dongfang Zhang; Sheldon E Litwin; Vlad G Zaha; Kimberly T Fountain; Sihem Boudina; Mercedes Jimenez-Linan; Margaret Blount; Miguel Lopez; Aline Meirhaeghe; Mohammad Bohlooly-Y; Leonard Storlien; Maria Strömstedt; Michael Snaith; Matej Oresic; E Dale Abel; Barbara Cannon; Antonio Vidal-Puig
Journal:  PLoS Biol       Date:  2006-11       Impact factor: 8.029

View more
  9 in total

Review 1.  Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology.

Authors:  Petra S Eisele; Christoph Handschin
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

2.  GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation.

Authors:  Timothy J Kelly; Carles Lerin; Wilhelm Haas; Steven P Gygi; Pere Puigserver
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

3.  Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cells.

Authors:  Hannes Oberkofler; Michael Hafner; Thomas Felder; Franz Krempler; Wolfgang Patsch
Journal:  J Mol Med (Berl)       Date:  2008-12-11       Impact factor: 4.599

4.  Regulation of skeletal muscle PPAR delta mRNA expression in twins.

Authors:  Emma Nilsson; Pernille Poulsen; Marketa Sjögren; Charlotte Ling; Martin Ridderstråle; Leif Groop; Allan Vaag
Journal:  J Physiol       Date:  2007-09-13       Impact factor: 5.182

5.  Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle.

Authors:  T Rönn; P Poulsen; O Hansson; J Holmkvist; P Almgren; P Nilsson; T Tuomi; B Isomaa; L Groop; A Vaag; C Ling
Journal:  Diabetologia       Date:  2008-05-17       Impact factor: 10.122

6.  The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes.

Authors:  Ildus I Ahmetov; Alun G Williams; Daniil V Popov; Ekaterina V Lyubaeva; Albina M Hakimullina; Olga N Fedotovskaya; Irina A Mozhayskaya; Olga L Vinogradova; Irina V Astratenkova; Hugh E Montgomery; Viktor A Rogozkin
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

7.  Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia.

Authors:  Iman S Gurung; Gema Medina-Gomez; Adrienn Kis; Michael Baker; Vidya Velagapudi; Sudeshna Guha Neogi; Mark Campbell; Sergio Rodriguez-Cuenca; Christopher Lelliott; Ian McFarlane; Matej Oresic; Andrew A Grace; Antonio Vidal-Puig; Christopher L-H Huang
Journal:  Cardiovasc Res       Date:  2011-06-01       Impact factor: 10.787

Review 8.  Epigenetics: a molecular link between environmental factors and type 2 diabetes.

Authors:  Charlotte Ling; Leif Groop
Journal:  Diabetes       Date:  2009-12       Impact factor: 9.461

9.  Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes.

Authors:  Gertrud Kacerovsky-Bielesz; Marek Chmelik; Charlotte Ling; Rochus Pokan; Julia Szendroedi; Michaela Farukuoye; Michaela Kacerovsky; Albrecht I Schmid; Stephan Gruber; Michael Wolzt; Ewald Moser; Giovanni Pacini; Gerhard Smekal; Leif Groop; Michael Roden
Journal:  Diabetes       Date:  2009-03-05       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.